Neuroscience-based Nomenclature (NbN)
The ECNP Taskforce on Nomenclature was established in 2010 to address a longstanding concern within the neuropsychopharmacological community that the nomenclature of psychotropic drugs did not properly reflect the underlying neuroscience of these compounds.
The essence of this concern was that inadequate nomenclature, on the one hand, made it more difficult to identify – and gain approval for – innovative treatments and, on the other, was confusing patients and exacerbating non-compliance, in both cases to the ultimate detriment of patient welfare.
The Taskforce, consisting of representatives from ACNP, AsCNP, CINP, ECNP, and IUPHAR, released the first edition of the new nomenclature at the 27th ECNP Congress.
The Neuroscience-based Nomenclature (NbN), is now available for free download on the iOS App Store and the Google Play Store.
Visit the website: http://www.nbn2.org/
Feature article: EBC News - Spring 2013
A proposal for an updated neuropsychopharmacological nomenclature, European Neuropsychopharmacology (August 2014)
The original proposed list of 109 compounds
| Download the app:
Give us your feedback
Please give us your feedback to help us to shape and improve the proposal. Thank you!